New capabilities will help 20% more customers with complex or chronic health needs access personalized clinical support earlier, reducing medical costs by $200M over three years
, /PRNewswire/ -- Cigna Healthcare®, the health benefits division of The Cigna Group (NYSE: CI), is significantly expanding its personalized care management programs through AI-enabled capabilities and predictive analytics that help identify customers who would benefit from earlier support and connect them with clinicians. The expansion will support 20% more customers with emerging, complex or chronic health needs – including cancer, heart disease, kidney disease, high-risk pregnancy, and behavioral health conditions.
AI-enabled capacities identify opportunities for personalized outreach and support, while experienced clinicians provide the guidance, care coordination, and expertise needed to help customers navigate their health journey with confidence. More than 1,250 Cigna Healthcare clinicians, including nurses and behavioral health specialists, guide customers as they navigate care, coordinate with multiple providers, and access additional resources. Through these new capabilities, clinicians will help customers address health needs earlier and manage conditions more effectively – reducing medical costs for engaged customers by $2,000 per year on average, resulting in an estimated $200 million in total savings over the next three years.
"As costs for hospital care, emergency services, and prescription drugs continue to rise, we are investing in tools and clinical programs that help customers avoid unnecessary hospitalizations, better manage chronic conditions, and reduce the likelihood of more serious and expensive health events later," said Bryan Holgerson, President, Cigna Healthcare U.S. and Executive Vice President, Customer Health Outcomes, The Cigna Group. "By combining predictive analytics, AI-enabled capabilities, and clinical expertise, we can identify health needs earlier and connect more customers with personalized support when it has the greatest impact."
Cigna Healthcare's care management programs have demonstrated meaningful results:
95% customer satisfaction among surveyed customers A 42% reduction in avoidable inpatient stays among customers who engage early with care management support Earlier identification of likely breast, colorectal, and lung cancer diagnoses by approximately 55, 46, and 37 days, respectively 72% of customers achieving clinically meaningful improvement in depression symptoms when connected to high-quality behavioral health providers "Health care can be difficult to navigate, especially when someone is facing a new diagnosis or complex condition. Our goal is to make it easier for customers to connect with an experienced Cigna Healthcare clinician who can help them understand their options and make the most of the support available through their health plan," said Dr. Stanley Crittenden, Chief Medical Officer, Cigna Healthcare. "With earlier guidance, we can help customers get the right care at the right time and avoid more serious and costly health complications."
How These Enhancements Improve Customer Experience
These AI-enabled capabilities help Cigna Healthcare identify opportunities to provide support earlier, personalize engagement, and connect more customers with experienced clinicians.
Earlier Identification of Support Opportunities: Advanced predictive models and AI-enabled insights help identify emerging health needs sooner, creating more opportunities to engage customers before a condition becomes more serious. More Personalized Engagement: Customers can connect with clinicians through the channels they prefer, including phone, text, email, and digital tools. These interactions create more opportunities to provide guidance, answer questions, and support healthier outcomes. Greater Access to Expert Clinical Support: AI-enabled capabilities help identify and prioritize engagement opportunities, allowing clinicians to focus more time on helping customers understand their options, coordinate care, and access resources. This work advances the company's commitments to create more connected, personalized health care experiences and complements services such as My Personal Champion, which helps customers navigate the administrative challenges that often accompany complex health conditions, including prior authorizations, claims, and continuity of care.
About Cigna Healthcare
Cigna Healthcare is a health benefits provider that advocates for better health through every stage of life. We guide our customers through the health care system, empowering them with the information and insight they need to make the best choices for improving their health and vitality. Products and services are provided exclusively by or through operating subsidiaries of The Cigna Group (NYSE:CI), including Cigna Health and Life Insurance Company, Connecticut General Life Insurance Company, Evernorth Health companies or their affiliates and Express Scripts companies or their affiliates. Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits, and others.
Learn more at www.cignahealthcare.com.
MEDIA CONTACT:
Gena Madow
[email protected]
240.513.5986
A screen displays the logo fro Cigna Corp. on the floor at the New York Stock Exchange (NYSE) in New York, U.S., July 16, 2019. REUTERS/Brendan McDermid/File Photo Purchase Licensing Rights, opens new tab
CompaniesNEW YORK, July 23 (Reuters) - Health insurer Cigna (CI.N), opens new tab said on Thursday that the artificial intelligence tools it is employing to identify patients with chronic or complex conditions will save customers $200 million in medical costs over the next three years.
Bryan Holgerson, a president at Cigna Healthcare, said the technology should reduce occurrences of more expensive health events, as costs for hospitalization and emergency services continue to increase. Cigna, using AI tools, plans to connect more members in its health insurance business to clinicians the company employs, such as nurses.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Cigna said the programming will allow its 1,250 clinicians to better manage a patient's healthcare needs and offer customized support earlier.
The changes will boost clinical access by 20% for people with conditions like cancer and heart or kidney disease, Cigna said in a press release. Cigna said it expects its new technology to help identify breast, colorectal and lung cancer earlier.
A Cigna spokesperson said company data estimates that customers using these clinical programs save $2,000 a year in medical costs.
The Cigna Group owns health insurer Cigna Healthcare, clinical business Evernorth Health Services and a pharmacy benefit manager, Express Scripts.
Rival UnitedHealth (UNH.N), opens new tab last week said tools the company has introduced this year have reduced the administrative burden for clinicians it employs through its Optum health services unit and increased the amount of time providers can spend treating patients.
CVS Health (CVS.N), opens new tab last week announced it plans to launch an AI assistant to call providers directly and book appointments on behalf of members.
Reporting by Amina Niasse; Editing by Will Dunham
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Resources Investor Relations Journalists Agencies Client Login Send a Release
News Products Contact Hamburger menu Send a Release
BLOOMFIELD, Conn., July 22, 2026 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.56 per share of its common stock, payable on September 23, 2026, to shareholders of record as of the close of business on September 8, 2026.
About The Cigna Group
The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Cigna Healthcare, Evernorth Health Services or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 markets and jurisdictions, and has over 180 million customer relationships around the world. Learn more at thecignagroup.com
Investor Relations Contact
Ralph Giacobbe
1 (860) 787-7968
[email protected]
Media Contact
Justine Sessions
1 (860) 810-6523
[email protected]
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.
Zacks Premium also includes the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.
Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFinding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to highlight the most attractive and discounted stocks.
Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.
Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.
VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.
How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.
It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +23.94% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.
That's where the Style Scores come in.
To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.
The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Cigna (CI - Free Report) Headquartered in Bloomfield, CT and formed in 1982, Cigna Corporation has rebranded itself as The Cigna Group. The company was formed as a result of a merger between Connecticut General Life Insurance Company and Insurance Company of North America. Cigna completed its combination with Express Scripts Holding Company by 2018-end. Shares of the new combined company trade on the NYSE under the stock ticker symbol “CI.”
CI is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
Momentum investors should take note of this Medical stock. CI has a Momentum Style Score of A, and shares are up 2.6% over the past four weeks.
One analyst revised their earnings estimate higher in the last 60 days for fiscal 2026, while the Zacks Consensus Estimate has increased $0.01 to $30.39 per share. CI also boasts an average earnings surprise of +1.9%.
With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, CI should be on investors' short list.
Allspring Global Investments Holdings LLC trimmed its position in shares of Cigna Group (NYSE:CI – Free Report) by 66.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 94,516 shares of the health services provider’s stock after selling 185,718 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Cigna Group were worth $25,266,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Wilkerson Advisory Group LLC bought a new position in Cigna Group in the 4th quarter valued at $25,000. Beacon Financial Strategies CORP bought a new position in shares of Cigna Group in the fourth quarter worth about $28,000. Kemnay Advisory Services Inc. bought a new position in shares of Cigna Group in the fourth quarter worth about $29,000. Prosperity Bancshares Inc purchased a new position in Cigna Group in the 4th quarter worth about $29,000. Finally, Cedar Mountain Advisors LLC increased its stake in Cigna Group by 161.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after buying an additional 68 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Cigna Group In other news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the sale, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is owned by company insiders.
Cigna Group Price Performance NYSE CI opened at $284.01 on Tuesday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The firm’s 50 day moving average price is $286.59 and its 200-day moving average price is $280.48. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47. The company has a market cap of $75.13 billion, a PE ratio of 12.04, a P/E/G ratio of 1.08 and a beta of 0.29.
Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.60 by $0.19. The company had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. Cigna Group’s revenue was up 4.6% compared to the same quarter last year. During the same period last year, the company posted $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Sell-side analysts forecast that Cigna Group will post 30.39 EPS for the current fiscal year.
Cigna Group Announces Dividend The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Thursday, June 4th were paid a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date was Thursday, June 4th. Cigna Group’s dividend payout ratio is 26.45%.
Wall Street Analyst Weigh In Several equities research analysts have issued reports on the stock. The Goldman Sachs Group boosted their price objective on shares of Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, June 20th. Sanford C. Bernstein boosted their price target on Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a report on Thursday, July 9th. UBS Group increased their price objective on Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research note on Friday, May 22nd. Finally, Morgan Stanley raised their price objective on Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a report on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Cigna Group has an average rating of “Moderate Buy” and an average target price of $338.80.
Check Out Our Latest Research Report on CI
Cigna Group Profile (Free Report)
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Articles Five stocks we like better than Cigna Group The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAllspring Global Investments Holdings LLC Lowers Position in HealthEquity, Inc. $HQY
NEXT HEADLINE »Allspring Global Investments Holdings LLC Increases Position in Altria Group, Inc. $MO
Angeles Wealth Management LLC cut its holdings in shares of Cigna Group (NYSE:CI – Free Report) by 52.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,772 shares of the health services provider’s stock after selling 4,145 shares during the period. Angeles Wealth Management LLC’s holdings in Cigna Group were worth $1,006,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors also recently modified their holdings of the business. apricus wealth LLC lifted its position in shares of Cigna Group by 715.9% in the fourth quarter. apricus wealth LLC now owns 9,505 shares of the health services provider’s stock valued at $2,616,000 after buying an additional 8,340 shares during the last quarter. CIBC Bancorp USA Inc. acquired a new stake in Cigna Group during the 3rd quarter valued at $10,617,000. Wilsey Asset Management Inc. boosted its position in Cigna Group by 5.1% during the fourth quarter. Wilsey Asset Management Inc. now owns 110,801 shares of the health services provider’s stock worth $30,496,000 after purchasing an additional 5,327 shares during the period. Nisa Investment Advisors LLC increased its holdings in shares of Cigna Group by 3.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 105,534 shares of the health services provider’s stock valued at $29,046,000 after purchasing an additional 3,814 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its stake in shares of Cigna Group by 4.8% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 95,023 shares of the health services provider’s stock worth $27,068,000 after buying an additional 4,394 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.
Cigna Group Trading Down 0.7% CI opened at $281.72 on Friday. The company has a market cap of $74.52 billion, a P/E ratio of 11.94, a PEG ratio of 1.09 and a beta of 0.29. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The company’s 50 day moving average is $286.68 and its 200-day moving average is $280.40. Cigna Group has a 1-year low of $239.51 and a 1-year high of $315.47.
Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The company had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. During the same period in the prior year, the company earned $6.74 EPS. Cigna Group’s revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities research analysts predict that Cigna Group will post 30.39 earnings per share for the current fiscal year.
Cigna Group Dividend Announcement The company also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th were issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date was Thursday, June 4th. Cigna Group’s payout ratio is 26.45%.
Insider Activity at Cigna Group In related news, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This trade represents a 27.52% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares in the company, valued at $10,054,560.34. This trade represents a 85.46% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.
Analyst Ratings Changes Several research firms have weighed in on CI. Mizuho increased their price target on shares of Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a report on Monday, June 8th. Weiss Ratings restated a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. Morgan Stanley increased their target price on Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 20th. The Goldman Sachs Group lifted their price target on Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Finally, Robert W. Baird set a $337.00 price objective on Cigna Group in a report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $338.80.
View Our Latest Stock Analysis on CI
Cigna Group Profile (Free Report)
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Recommended Stories Five stocks we like better than Cigna Group AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAllspring Global Investments Holdings LLC Lowers Stock Holdings in Regal Rexnord Corporation $RRX
NEXT HEADLINE »Modine Manufacturing Company $MOD Shares Bought by Allspring Global Investments Holdings LLC
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
Zacks Premium includes access to the Zacks Style Scores as well.
What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.
Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFinding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to highlight the most attractive and discounted stocks.
Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.
Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.
VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.
How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.
Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.94% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.
That's where the Style Scores come in.
To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.
Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Cigna (CI - Free Report) Headquartered in Bloomfield, CT and formed in 1982, Cigna Corporation has rebranded itself as The Cigna Group. The company was formed as a result of a merger between Connecticut General Life Insurance Company and Insurance Company of North America. Cigna completed its combination with Express Scripts Holding Company by 2018-end. Shares of the new combined company trade on the NYSE under the stock ticker symbol “CI.”
CI is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
It also boasts a Value Style Score of A thanks to attractive valuation metrics like a forward P/E ratio of 9.28; value investors should take notice.
One analyst revised their earnings estimate higher in the last 60 days for fiscal 2026, while the Zacks Consensus Estimate has increased $0.01 to $30.39 per share. CI also boasts an average earnings surprise of +1.9%.
With a solid Zacks Rank and top-tier Value and VGM Style Scores, CI should be on investors' short list.
, /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its second quarter 2026 financial results on Thursday, July 30, 2026, and will host a conference call the same day.
Second quarter 2026 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows:
Live Call
(888) 566-1889 (Domestic)
(773) 799-3989 (International)
Passcode: 07302026
It is strongly suggested that participants dial in to the conference call by 8:15 a.m. ET on July 30, 2026. A replay of the call will be available from 12:30 p.m. ET on July 30, 2026 until 10:59 p.m. ET on August 13, 2026. Additionally, the conference call will be available on a live internet webcast at https://investors.thecignagroup.com/events-and-presentations/default.aspx in the Investor Relations section of The Cigna Group's website. Please note that this feature will be in listen-only mode.
A copy of the company's news release and financial supplement will be available on The Cigna Group's website in the Investor Relations section at https://investors.thecignagroup.com/overview/default.aspx, no later than 6:30 a.m. ET on July 30, 2026.
About The Cigna Group
The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Cigna Healthcare, Evernorth Health Services or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 markets and jurisdictions, and has over 185 million customer relationships around the world. Learn more at thecignagroup.com.
Investor Relations Contact
Ralph Giacobbe
1 (860) 787-7968
[email protected]
Media Contact
Justine Sessions
1 (860) 810-6523
[email protected]
Key Takeaways CI is rolling out Pharmacy Forward through Accredo to simplify specialty pharmacy with AI.Cigna expects faster prescription processing, lower admin work and stronger medication adherence.Evernorth's Q1 2026 adjusted revenues rose 9%, while Specialty and Care Services earnings grew 20%. The Cigna Group’s (CI - Free Report) health services division, Evernorth, has launched Pharmacy Forward, an AI-powered specialty pharmacy initiative designed to simplify and accelerate the prescription journey for patients with complex conditions. Backed by a $100 million investment through 2028, the program will first roll out through Accredo Specialty Pharmacy. By using artificial intelligence across prescription intake, clinical support and fulfilment, the platform aims to reduce delays, improve communication and help patients start treatment sooner.
The platform is expected to make specialty pharmacy operations more efficient for both patients and healthcare providers. Pharmacy Forward is projected to cut prescription processing times in half while reducing clinicians' administrative work. It also expands personalized digital support to improve medication adherence. Another advantage is its logistics network, with 90% of Accredo patients living within a one-day ground delivery radius. The initiative is expected to generate nearly $400 million in cumulative value by the end of 2028.
The launch fits into Cigna's broader plan to expand Evernorth Health Services, a key growth driver. The company has been investing in technology to simplify pharmacy services, improve efficiency and encourage biosimilar adoption. The strategy is already showing results. In the first quarter of 2026, Evernorth's adjusted revenues rose 9% year over year to $58.4 billion, while pretax adjusted earnings in its Specialty and Care Services business increased 20%.
Pharmacy Forward highlights Cigna's continued push to grow its healthcare services business beyond traditional insurance. Although the investment is unlikely to have a meaningful impact on near-term earnings, it could strengthen Evernorth's position in the growing specialty pharmacy market by improving efficiency and patient experience. Combined with higher adjusted EPS guidance for 2026 and the leadership of CEO Brian Evanko, the initiative reinforces Cigna's long-term growth strategy.
Cigna’s Stock Price PerformanceShares of Cigna have gained 0.7% year to date compared with the industry’s 25.2% gain over the same period.
Image Source: Zacks Investment Research
Cigna’s Zacks Rank & Key PicksCI currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader Medical space are UnitedHealth Group Incorporated (UNH - Free Report) , Elevance Health, Inc. (ELV - Free Report) and CVS Health Corporation (CVS - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for UnitedHealth Group’s 2026 earnings is pegged at $18.32 per share, indicating 12.05% year-over-year growth. UNH beat earnings estimates in three of the trailing four quarters and missed once, with the average surprise being 0.8%. The consensus estimate for 2026 revenues is pinned at $443.7 billion.
The Zacks Consensus Estimate for Elevance Health’s 2026 earnings is pegged at $26.86 per share, which has witnessed one upward revision in the past 30 days, with no movement in the opposite direction. ELV beat earnings estimates in three of the trailing four quarters and missed once, with the average surprise being 10.6%. The consensus estimate for 2026 revenues is pinned at $ 194.24 billion.
The Zacks Consensus Estimate for CVS Health’s 2026 earnings is pegged at $7.44 per share, indicating 10.22% year-over-year growth. CVS beat earnings estimates in each of the trailing four quarters, with the average surprise being 16.8%. The consensus estimate for 2026 revenues is pinned at $409 billion, implying 1.7% year-over-year growth.
New program introduces AI-enabled capabilities to personalize support, streamline prescription processing, and help patients start and stay on therapy with greater ease and confidence
, /PRNewswire/ -- As specialty care becomes more complex, patients need faster, more connected, and personalized support. To help meet that need, Evernorth, the health services division of The Cigna Group (NYSE:CI), today unveiled Pharmacy Forward, a new AI-powered program designed to improve how patients access and experience specialty care. Launching first with Accredo Specialty Pharmacy – which serves patients with chronic and complex specialty conditions through condition-specific Therapeutic Resource Centers (TRCs) – the program is supported by a $100 million investment through 2028. This investment enables care teams to focus more on clinical care and patient outcomes while reducing prescription processing timelines and improving service responsiveness.
"Patients navigating complex health conditions need comprehensive, expert support, often during some of the most difficult moments in their lives," said Matt Perlberg, President of the Evernorth Health Services pharmacy and care delivery businesses, including Accredo, and Executive Vice President of Customer Innovation for The Cigna Group. "Pharmacy Forward reflects our commitment to meet patients where they are —delivering an even faster, more seamless experience while ensuring they receive the personalized support and clinical care they deserve."
A Smarter, Faster, More Personalized Specialty Pharmacy Experience
Pharmacy Forward applies AI across four core areas: clinical care, prescription intake, administration, and medication fulfillment:
Care Enablement — Supporting More Coordinated, Insight-Driven Care: Pharmacy Forward is expected to improve medication adherence beyond the industry standard of 80%, helping patients stay on therapy and achieve optimal health outcomes. By integrating clinical data and insights, AI-generated summaries, and predictive analytics, care teams can deliver more connected, informed support. This enables clinicians to proactively identify patients at risk of falling off therapy or experiencing adverse events, empowering earlier intervention, stronger coordination, and an improved patient experience. The program uses AI to free up more time for clinicians to focus on patient care and is expected to reduce clinician documentation time by up to 50%. Experience Accelerators – Improving the Patient Journey in Real Time: Pharmacy Forward uses AI-enabled tools to reach patients earlier in their care journey and deliver more proactive, personalized support. For example, Accredo has implemented AI-enabled scheduling so outreach occurs during patients' preferred call windows. Additionally, Accredo anticipates a 25% increase in use of personalized patient digital pathways, enabling more patients to complete routine steps on their own terms — getting answers faster, starting prescriptions through the app or website, and scheduling therapy more easily. Rx Readiness — Accelerating Time to Therapy: Pharmacy Forward is cutting the time it takes for patients to receive their medication after Accredo receives a prescription in half — helping patients start treatment sooner. By using AI to improve the completeness of prior authorization submissions, identify copay assistance eligibility, and ensure prescriptions are ready earlier in the process, the program is designed to streamline the time it takes to process a prescription and reduce delays in care. One Fulfillment Network — Delivering Medications Faster and More Reliably: Pharmacy Forward will enhance Accredo's ability to ship complex specialty medications from sites as close to a patient's home as possible, ensuring that 90% of patients are within a 1-day or same day ground shipping radius. To enable this, Accredo is expanding capacity, staffing, and capabilities at many of its nearly 40 care facilities to reduce the need for longer ground or air shipments, which are more susceptible to delays from adverse events such as weather. The enhancements will be supported by AI technology, for example, to continuously analyze factors such as patient location, delivery timing, and medication handling requirements to determine the most effective dispensing location. Together, these capabilities represent the next evolution of specialty pharmacy — combining AI, clinical expertise, and operational scale to create a more connected and responsive care experience. The program is expected to generate approximately $400 million in value by the end of 2028, helping make care more coordinated and personalized for the more than one million patients Accredo serves each year. Evernorth expects to extend many of these capabilities to its other pharmacies' operations in the coming years.
"AI is enabling us to fundamentally reimagine how we support each patient's journey," said Katya Andresen, Chief Data, Digital and AI Officer, The Cigna Group. "By responsibly combining real-time data, advanced analytics and deep clinical expertise, we can deliver more personalized, proactive support — helping people access the care they need faster and achieve better health outcomes."
About Evernorth Health Services
Evernorth Health Services is the pharmacy, care, and benefits solutions division of The Cigna Group (NYSE: CI). We create and deliver innovative, flexible, and people-first solutions that solve the most complex health care challenges. Evernorth is home to pioneering brands including Express Scripts, Express Scripts Pharmacy, Accredo, eviCore, and MD Live. We have more than 40,000 employees who work to make health care more affordable, predictable, and simple for the 190 million people we serve. Learn more at evernorth.com.
Media Contact
Justine Sessions
[email protected]
860-810-6523
Key Takeaways Cigna is broadening its business with pharmacy services, specialty care and AI-driven solutions.CI raised its 2026 adjusted EPS outlook and is reshaping its portfolio toward higher-growth areas.Evernorth is fueling growth with pharmacy benefits, specialty pharmacy and care services. If you still think of The Cigna Group (CI - Free Report) as just a traditional health insurer, it may be time for a second look. The company is steadily expanding beyond insurance, building a broader healthcare platform centered on pharmacy services, specialty care and AI-powered solutions. The strategy is beginning to deliver results.
Evernorth, Cigna's health services business, is driving much of the company's transformation. Its pharmacy benefits, specialty pharmacy and care services businesses are helping deliver more affordable, personalized care. In the first quarter of 2026, Evernorth's adjusted revenues grew 9% year over year to $58.4 billion.
Technology is becoming another key growth driver. Cigna is using AI and advanced analytics to streamline prescriptions, identify high-risk patients earlier and improve customer engagement. Its rebate-free Signature pharmacy model aims to lower out-of-pocket drug costs, while AI helps simplify the pharmacy experience.
Cigna is also reshaping its portfolio. Investments in CarepathRx and Shields Health Solutions have strengthened its specialty pharmacy business. It also plans to exit the individual exchange business and is reviewing strategic alternatives for eviCore. These moves should help management direct more resources toward its higher-growth businesses.
Management's confidence in the strategy is growing. Following a strong first quarter, Cigna raised its 2026 adjusted EPS outlook by 10 cents to at least $30.35 per share. Cigna's push beyond traditional health insurance is still unfolding, but its growing focus on AI, specialty pharmacy and healthcare services is opening new avenues for long-term growth.
How Are Cigna's Peers Positioned?Cigna isn't alone in this shift. Peers in the Medical space, like UnitedHealth Group Incorporated (UNH - Free Report) and CVS Health Corporation (CVS - Free Report) are also investing in technology-enabled healthcare services, making innovation a key differentiator across the industry.
UnitedHealth is pursuing a similar strategy through Optum, which combines pharmacy services, care delivery and technology. Growth in Optum Rx and commercial fee-based membership supported previous quarter’s results. UNH is also expanding its AI and analytics capabilities while rolling out a transparent, fee-based pharmacy care model.
CVS Health is also broadening its healthcare platform through pharmacy services, digital innovation and care delivery. CVS continues to expand AI-powered member engagement and digital onboarding at Aetna while strengthening CVS Caremark and its Health Care Delivery business.
Cigna’s Price Performance, Valuation & EstimatesShares of Cigna have risen 1.6% year to date compared with the industry’s 22.8%. growth
Image Source: Zacks Investment Research
From a valuation standpoint, Cigna trades at a forward price-to-earnings ratio of 8.78X compared with the industry average of 17.75X. CI carries a Value Score of C.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Cigna’s 2026 earnings is pegged at $30.39 per share, implying a 1.8% increase from the year-ago period’s level.
Image Source: Zacks Investment Research
Cigna currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
New "Courage in Service" grant builds on company's long-standing support for military and veteran communities.
, /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), today announced the launch of the David M. Cordani Courage in Service Grant, a new $1.5 million, 10-year commitment to support the health and well-being of military and veteran communities by prioritizing social connection.
The Cigna Group Foundation Honors David M. Cordani’s Leadership with New Grant to Strengthen Military Communities The grant comes as Cordani, who has served as chief executive officer of The Cigna Group for 17 years, is set to retire as CEO and become executive chair of the company's Board of Directors. It builds on the Foundation's and Cordani's long-standing focus on improving the health and vitality of military and veteran communities through trusted community-based support networks.
Each year, $150,000 will be awarded to one nonprofit serving military and veteran communities to support programs that strengthen connections, improve well-being, and increase stability for individuals and families navigating key life transitions.
"This new grant honors David Cordani's 17 years as CEO of The Cigna Group and his unwavering commitment to those who serve our country," said Melissa Skottegaard, board chair of The Cigna Group Foundation. "Throughout his tenure, David has championed initiatives that expand access to care and opportunity for veterans and military families—guided by a deep respect for their service. It is fitting that this fund extends his legacy, helping ensure veterans and military have the support they need for their best health and vitality."
How the Grant Supports Military Communities
The Courage in Service Grant will support nonprofit organizations that deliver:
Programs that reduce isolation and strengthen resilience among military families through peer support Community-centered health and wellness hubs offering physical activity, wellness programming, and mental health support Transition-focused services that help individuals and families navigate key military life moments such as deployment, relocation, recovery, and reintegration Learn more about The Cigna Group Foundation's programs and impact here.
Grant Applications Now Open, Deadline to Apply July 30, 2026
The Courage in Service Grant is open to eligible nonprofit organizations across the United States. Interested organizations can visit The Cigna Group Foundation's website to review program requirements, eligibility criteria, and application instructions. Grant requests must total $150,000 for a one-year period.
Applications are open now through Thursday, July 30, 2026, at 5:00 p.m. ET. A single grantee will be announced later this year, with the grant term beginning January 1, 2027.
About The Cigna Group Foundation
The Cigna Group Foundation is a private foundation funded by contributions from The Cigna Group (NYSE:CI) and its subsidiaries. The Cigna Group Foundation aims to support, collaborate, and convene with nonprofit organizations addressing society's greatest health challenges. In addition to increasing access to programs and care in geographies demonstrating significant need, the Foundation responds with humanitarian aid relief during critical times and strengthens colleagues' support of causes through matching donations and volunteer rewards. To learn more, visit www.thecignagroup.com/community.
About The Cigna Group:
The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Cigna Healthcare, Evernorth Health Services or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 countries and jurisdictions and has more than 180 million customer relationships around the world. Learn more at www.thecignagroup.com.
Media Contact:
Danielle DiStefano
[email protected]
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
Zacks Premium also includes the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.
Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.
The Style Scores are broken down into four categories:
Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.
Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.
Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.
VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.
#1 (Strong Buy) stocks have produced an unmatched +24% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.
But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.
That's where the Style Scores come in.
To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.
The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.
Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Cigna (CI - Free Report) Headquartered in Bloomfield, CT and formed in 1982, Cigna Corporation has rebranded itself as The Cigna Group. The company was formed as a result of a merger between Connecticut General Life Insurance Company and Insurance Company of North America. Cigna completed its combination with Express Scripts Holding Company by 2018-end. Shares of the new combined company trade on the NYSE under the stock ticker symbol “CI.”
CI is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
Momentum investors should take note of this Medical stock. CI has a Momentum Style Score of A, and shares are up 0.8% over the past four weeks.
Eight analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.06 to $30.39 per share. CI boasts an average earnings surprise of +1.9%.
With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, CI should be on investors' short list.
Despite global geopolitical uncertainties and the ongoing conflict in the Middle East, the U.S. economy is showing signs of accelerating growth in the second quarter after a relatively soft start to the year. As often happens, stock market volatility is creating a lot of unease that masks the positive fundamentals. Legitimate concerns about stock market valuations are being stoked by unnerving headlines that ignore solid, and even improving, economic fundamentals. This can be a harsh reality in a mid-term election year, especially given the 24-hour news cycle, though we think that volatility creates opportunity for investors.
For example, forecasts for second quarter GDP growth reflect a resilient economy while headlines generate wide swings in stock markets. Federal Reserve Banks provide real-time tracking (nowcasts) for current quarter GDP growth, while the Bureau of Economic Analysis publishes official GDP statistics and revisions weeks and months after the quarter has ended. Two of the most prominent nowcast models, the New York Fed Staff Nowcast and the Atlanta Fed GDPNow, project second quarter growth at 2.7% and 3.3%, respectively, compared to 1.6% annualized growth in the first quarter.
The official GDP estimate for the second quarter will not be released until late July, so there is still time for data to drive further revisions before then. However, the information we can track now, especially related to the labor market, suggests solid growth in the current quarter.
The strong employment report for June further supports our positive economic growth narrative. Following the February jobs losses, the months since have bounced back significantly (exhibit 2). Though the six-month moving average is still below the previous business cycle average, the recent uptick is moving in the right direction.
In addition, it is clear that the U.S. infrastructure buildout is having a significant impact on economic growth. Private fixed investment, which is the combination of structures, equipment, and research and development investments, has been growing for years.
Though projects in support of artificial intelligence (AI) have taken the lead, the increased investments in plant and equipment and related infrastructure began years before the AI research and development buildout went mainstream. Crucially, the investment in AI is no longer just a software narrative. This immense capital spending is filtering directly into the physical economy and driving significant revenue into industrial manufacturing, electrical equipment makers, and the energy grid infrastructure. These substantial capital investments should push long-term worker efficiency. Over time, these productivity gains can help support economic growth while naturally moderating broader inflationary pressures.
We expect these investments to have payoffs that will last for years into the future and are a primary reason we think that the next decade of U.S. economic growth will likely be stronger than anything we have seen since the 1990s.
INVESTMENT IMPLICATIONS As a result, our Strategies remain tilted in favor of U.S. equities. At the sector level, we continue to emphasize financials (e.g., regional banks), industrials, and information technology. Within fixed income, we increased our exposure to mortgage-backed securities to capture attractive yields and a favorable risk/reward profile, while continuing to prefer the belly of the yield curve and high-quality asset-backed securities. With respect to our alternative investment allocations, we continue to favor equity option overlay strategies for current income and a multi-asset real return strategy for inflation mitigation and lower-correlation total returns. Our positioning is designed to be resilient across a range of geopolitical and energy-market outcomes. In our base case scenario, we consider volatility as an opportunity when selectively considering the current valuations.
THE CASH INDICATOR Our Cash Indicator (CI) has held steadily at levels below the long-term median all year, despite bouts of equity market volatility. The fixed income market has continued to reflect confidence in the economy and financial markets while keeping the CI relatively steady. Overall, the recent equity market volatility looks like a healthy reset back to “normal” levels of caution rather than a signal of trouble as we remain well below the point where the CI would call for moving to cash.
For more news, information, and analysis, visit the ETF Strategist Content Hub.
DISCLOSURES Shelton Capital Management is an investment adviser in Denver, CO. Shelton Capital Management is registered with the Securities and Exchange Commission (SEC). Registration of an investment adviser does not imply any specific level of skill or training and does not constitute an endorsement of the firm by the Commission. Shelton Capital Management only transacts business in states in which it is properly registered or is excluded or exempted from registration. Some of the firm’s strategies allocate client’s investment management assets among exchange-traded funds (“ETFs”). A GIPS Report along with a complete list and description of all composites is available by calling (800) 955-9988. A copy of Shelton Capital Management’s current written disclosure brochure filed with the SEC which discusses among other things, Shelton Capital Management’s business practices, services and fees, is available through the SEC’s website at: www.adviserinfo.sec.gov. INVESTMENTS ARE NOT FDIC INSURED OR BANK GUARANTEED AND MAY LOSE VALUE. The views contained herein are not be taken as an advice or a recommendation to buy or sell any investment and the material should not be relied upon as containing sufficient information to support an investment decision. It should be noted that the value of investments and the income from them may fluctuate in accordance with market conditions and taxation agreements and investors may not get back the full amount invested.
Past performance and yield may not be a reliable guide to future performance. Current performance may be higher or lower than the performance quoted. The securities identified and described may not represent all of the securities purchased, sold or recommended for client accounts. The reader should not assume that an investment in the securities identified was or will be profitable.
Data is provided by various sources and prepared by Shelton Capital Management and has not been verified or audited by an independent accountant.
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.
It also includes access to the Zacks Style Scores.
What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.
Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.
Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.
VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.
#1 (Strong Buy) stocks have produced an unmatched +24% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.
With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.
That's where the Style Scores come in.
To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.
Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.
For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Cigna (CI - Free Report) Headquartered in Bloomfield, CT and formed in 1982, Cigna Corporation has rebranded itself as The Cigna Group. The company was formed as a result of a merger between Connecticut General Life Insurance Company and Insurance Company of North America. Cigna completed its combination with Express Scripts Holding Company by 2018-end. Shares of the new combined company trade on the NYSE under the stock ticker symbol “CI.”
CI is a #3 (Hold) on the Zacks Rank, with a VGM Score of B.
It also boasts a Value Style Score of A thanks to attractive valuation metrics like a forward P/E ratio of 9.38; value investors should take notice.
Eight analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.06 to $30.39 per share. CI boasts an average earnings surprise of +1.9%.
With a solid Zacks Rank and top-tier Value and VGM Style Scores, CI should be on investors' short list.
NOT FOR DISSEMINATION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA
TORONTO--(BUSINESS WIRE)--CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month or quarter ending June 30, 2026 for the ETFs managed by CI GAM with a payment date of July 8, 2026. The payment will be made to unitholders of record on June 29, 2026. The ex-dividend date for all ETFs is June 29, 2026.
The following ETFs trade on the Toronto Stock Exchange with the exception of Invesco Long Term Government Bond Index ETF (PGL) and Invesco S&P Europe 350 Equal Weight Index ETF (EQE, EQE.F), which trade on the Cboe Canada exchange.
ETF
Trading
Symbol (1)
Distribution
Amount (per
unit in $)
Payment
Frequency
Fixed income
Invesco Canadian Government Floating Rate Index ETF – CAD
PFL
0.0390
Monthly
Invesco 1-5 Year Laddered Investment Grade Corporate Bond Index ETF – CAD
PSB
0.0480
Monthly
Invesco Long Term Government Bond Index ETF – CAD
PGL
0.0527
Monthly
Invesco US Treasury Floating Rate Note Index ETF (USD) – USD
IUFR.U
0.0619
Monthly
Invesco Canadian Core Plus Bond ETF – CAD
ICCB
0.0686
Monthly
Invesco Global Bond ETF – CAD
ICGB
0.0656
Monthly
ESG fixed income
Invesco ESG Canadian Core Plus Bond ETF – CAD
BESG
0.0548
Monthly
Invesco ESG Global Bond ETF – CAD
IWBE
0.0531
Monthly
Equity income
Invesco Canadian Dividend Index ETF – CAD
PDC
0.1339
Monthly
Invesco S&P/TSX Canadian Dividend Aristocrats ESG Index ETF – CAD
ICAE
0.0677
Monthly
Invesco S&P US Dividend Aristocrats ESG Index ETF – CAD
IUAE
0.0344
Monthly
Invesco S&P US Dividend Aristocrats ESG Index ETF – CAD Hedged
IUAE.F
0.0315
Monthly
Invesco S&P International Developed Dividend Aristocrats ESG Index ETF – CAD
IIAE
0.0746
Monthly
Invesco S&P International Developed Dividend Aristocrats ESG Index ETF –CAD Hedged
IIAE.F
0.0706
Monthly
Low-volatility equity
Invesco S&P 500 Low Volatility Index ETF – CAD
ULV.C
0.0616
Monthly
Invesco S&P 500 Low Volatility Index ETF – CAD Hedged
ULV.F
0.0844
Monthly
Invesco S&P 500 Low Volatility Index ETF – USD
ULV.U
0.0440
Monthly
Invesco S&P/TSX Composite Low Volatility Index ETF – CAD
TLV
0.1186
Monthly
ESG equity income
Invesco ESG NASDAQ 100 Index ETF – CAD
QQCE
0.0271
Quarterly
Invesco ESG NASDAQ 100 Index ETF – CAD Hedged
QQCE.F
0.0208
Quarterly
Invesco S&P 500 ESG Index ETF – CAD
ESG
0.1083
Quarterly
Invesco S&P 500 ESG Index ETF – CAD Hedged
ESG.F
0.0958
Quarterly
Invesco S&P/TSX Composite ESG Index ETF – CAD
ESGC
0.2058
Quarterly
Invesco S&P International Developed ESG Index ETF – CAD
IICE
0.1356
Quarterly
Invesco S&P International Developed ESG Index ETF – CAD Hedged
IICE.F
0.1453
Quarterly
Equal weight equity
Invesco S&P 500 Equal Weight Income Advantage ETF – CAD
Invesco S&P 500 Equal Weight Income Advantage ETF – USD
EQLI.U
0.1525
Monthly
Invesco S&P 500 Equal Weight Index ETF – CAD
EQL
0.1445
Quarterly
Invesco S&P 500 Equal Weight Index ETF – CAD Hedged
EQL.F
0.1168
Quarterly
Invesco S&P 500 Equal Weight Index ETF – USD
EQL.U
0.1036
Quarterly
Invesco S&P Europe 350 Equal Weight Index ETF – CAD
EQE
0.1725
Quarterly
Invesco S&P Europe 350 Equal Weight Index ETF – CAD Hedged
EQE.F
0.1696
Quarterly
Invesco S&P/TSX 60 Equal Weight Index ETF – CAD
EQLT
0.1459
Quarterly
Fundamental Index® methodology equity
Invesco RAFI Canadian Index ETF – CAD
PXC
0.3563
Quarterly
Invesco RAFI Global Small-Mid ETF – CAD
PZW
0.1394
Quarterly
Invesco RAFI Global Small-Mid ETF – CAD Hedged
PZW.F
0.0972
Quarterly
Invesco RAFI Global Small-Mid ETF – USD
PZW.U
0.0992
Quarterly
Invesco RAFI U.S. Index ETF II – CAD
PXS
0.1788
Quarterly
Invesco RAFI U.S. Index ETF II – USD
PXS.U
0.1276
Quarterly
Invesco RAFI U.S. Index ETF – CAD Hedged
PXU.F
0.2231
Quarterly
U.S. equity
Invesco NASDAQ 100 Income Advantage ETF – CAD
QQCI
0.2112
Monthly
Invesco NASDAQ 100 Income Advantage ETF – CAD Hedged
QQCI.F
0.1731
Monthly
Invesco NASDAQ 100 Income Advantage ETF – USD
QQCI.U
0.1740
Monthly
Invesco NASDAQ 100 Index ETF – CAD
QQC
0.0398
Quarterly
Invesco NASDAQ 100 Index ETF – CAD Hedged
QQC.F
0.1844
Quarterly
Invesco NASDAQ 100 Equal Weight Index ETF – CAD
QQEQ
0.0473
Quarterly
Invesco NASDAQ 100 Equal Weight Index ETF – CAD Hedged
QQEQ.F
0.0382
Quarterly
Invesco NASDAQ Next Gen 100 Index ETF – CAD
QQJR
0.0223
Quarterly
Invesco NASDAQ Next Gen 100 Index ETF – CAD Hedged
QQJR.F
0.0177
Quarterly
Invesco Russell 1000 Multifactor Index ETF – CAD
IUMF
0.0530
Quarterly
Invesco Russell 1000 Multifactor Index ETF – CAD Hedged
IUMF.F
0.0477
Quarterly
Global equity
Invesco Morningstar Global Energy Transition Index ETF – CAD
IGET
0.0375
Quarterly
Invesco Morningstar Global Energy Transition Index ETF – CAD Hedged
IGET.F
0.0350
Quarterly
Invesco Morningstar Global Next Gen AI Index ETF – CAD
INAI
0.0004
Quarterly
Invesco Morningstar Global Next Gen AI Index ETF – CAD Hedged
INAI.F
0.0013
Quarterly
International equity
Invesco International Developed Multifactor Index ETF – CAD
IIMF
0.1483
Quarterly
Invesco International Developed Multifactor Index ETF – CAD Hedged
IIMF.F
0.1462
Quarterly
1 A ticker symbol ending with “.U” represents U.S.-dollar-denominated units. USD units of these ETFs are offered as a convenience for investors who wish to purchase with U.S. dollars and receive distributions and the proceeds of sale or redemption in U.S. dollars. The USD units are not hedged against changes in the exchange rate between the Canadian dollar and the U.S. dollar.
About CI Global Asset Management
CI Global Asset Management (“CI GAM”) is one of Canada’s leading investment management firms, providing a comprehensive suite of solutions – including mutual funds, exchange-traded funds and alternative investments – to help Canadians achieve their financial goals. Founded in 1965, CI GAM has built an enduring legacy of innovation, disciplined portfolio management and commitment to investor success. We partner with financial advisors, wealth management firms and institutions to serve more than 1.3 million investors. CI GAM is a subsidiary of Toronto-based CI Financial Corp., a diversified global asset and wealth management company. For more information, visit www.ci.com or follow us on LinkedIn.
Commissions, management fees and expenses all may be associated with an investment in exchange-traded funds (ETFs). You will usually pay brokerage fees to your dealer if you purchase or sell units of an ETF on recognized Canadian exchanges. If the units are purchased or sold on these Canadian exchanges, investors may pay more than the current net asset value when buying units of the ETF and may receive less than the current net asset value when selling them. Please read the prospectus before investing. Important information about an exchange-traded fund is contained in its prospectus. ETFs are not guaranteed; their values change frequently, and past performance may not be repeated.
This communication is intended for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to purchase mutual funds managed by CI Global Asset Management and is not, and should not be construed as, investment, tax, legal or accounting advice, and should not be relied upon in that regard. Every effort has been made to ensure that the material contained in this document is accurate at the time of publication. Individuals should seek the advice of professionals, as appropriate, regarding any particular investment. Investors should consult their professional advisors prior to implementing any changes to their investment strategies. These investments may not be suitable to the circumstances of an investor.
Certain names, words, titles, phrases, logos, icons, graphics, or designs in this document may constitute trade names, registered or unregistered trademarks or service marks of CI Investments Inc., its subsidiaries, or affiliates, used with permission. All other marks are the property of their respective owners and are used with permission.
The indices referenced are products of S&P Dow Jones Indices LLC or its affiliates (“SPDJI”) and/or TSX, Inc., and have been licensed for use by CI Global Asset Management (“CI GAM”). S&P® and S&P 500® are trademarks of S&P Global, Inc. or its affiliates (“S&P”); Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC (“Dow Jones”); TSX is a trademark of TSX, Inc., and these trademarks have been licensed for use by SPDJI and sublicensed for certain purposes by CI GAM. The CI ETFs are not sponsored or sold by SPDJI, Dow Jones, S&P, their respective affiliates or TSX, Inc., and none of such parties make any representation regarding the advisability of investing in such products nor do they have any liability for any errors, omissions, or interruptions of the indices.
Morningstar® is a registered trademark of Morningstar, Inc. The securities of each ETF are not in any way sponsored, endorsed, sold or promoted by Morningstar or any of its affiliates (collectively, "Morningstar"), and Morningstar makes no representation or warranty, express or implied, regarding the advisability of investing in securities generally or in the ETFs.
Russell® is a trademark of Frank Russell Company, part of London Stock Exchange Group. The Russell 1000 Dynamic‑Multifactor Index is calculated by Russell. Russell does not sponsor, endorse, or promote this product and is not affiliated with it and accepts no liability in relation to its use, operation, or trading. The applicable RAFI index is a service mark of RAFI Indices, LLC or its affiliates and is licensed for use by CI Global Asset Management. The Product is not sponsored, endorsed, sold or promoted by RAFI or its agents. RAFI makes no representation regarding the advisability of investing in the ETF. In no event will RAFI and its agents be liable for any damages, including direct, indirect, special, punitive and consequential damages (including lost profits) with respect to the Product or Index.
Nasdaq®, Nasdaq-100®, and related marks are registered trademarks of Nasdaq, Inc. (which, together with its affiliates, are referred to as the “Corporations”) and are licensed for use by CI Global Asset Management. The Product(s) have not been passed on by the Corporations as to their legality or suitability and are not issued, endorsed, sold, or promoted by the Corporations. THE CORPORATIONS MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO THE PRODUCT(S).
Invesco® and all associated trademarks are trademarks of Invesco Holding Company Limited, and used by CI Global Asset Management under licence.
The CI Exchange-Traded Funds are managed by CI Global Asset Management, a wholly owned subsidiary of CI Financial Corp.
CI Global Asset Management is a registered business name of CI Investments Inc.
22 nonprofits will expand access to youth mental health care and strengthen support for families and caregivers
States: Arizona, Connecticut, Florida, Georgia, Illinois, Missouri, New Jersey, Pennsylvania, Tennessee and Texas
, /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), today announced $3 million in grants to 22 nonprofits working to improve youth mental health and strengthen support systems across 10 states. Youth mental health needs continue to outpace access to care in many communities, particularly for young people and families navigating limited resources.
Campers participate in activities at Camp Erin Philadelphia, a grief program for youth who have experienced the death of a significant person in their lives. Camp Erin is hosted by Eluna, a grantee of The Cigna Group Foundation.
Employees from The Cigna Group volunteer with local children and teens in California - in partnership with Boys & Girls Clubs of America. "Too many young people still face barriers to getting the mental health support they need," said Ellie Polack, president of The Cigna Group Foundation. "We're proud to play a role in helping these organizations expand access to care, strengthen local support systems, and reach more youth and families earlier."
The grants are part of the Foundation's three-year, $9 million commitment to youth mental health. The program focuses on:
Expanding access to youth mental health services for ages 5-18 Equipping parents, caregivers, educators, and youth service professionals Strengthening pathways to early intervention and care Of the 22 grantees, 40 percent are continuing or expanding programs funded in earlier years of the Foundation's commitment. Eluna, a multi-state nonprofit supporting youth and families experiencing grief, is among the organizations receiving continued support.
"Our Eluna Resource Center slogan is, 'wherever you are, we are there for you', and we are so thankful The Cigna Group Foundation has provided us with the opportunity to make that a reality for so many more families," said Mary FitzGerald, CEO of Eluna. "We're excited to be going into our third year of programming with The Cigna Group Foundation's support, offering more family grief camp programs, caregiver workshops, and volunteer opportunities. This funding helps youth and their caregivers feel empowered and less alone."
The grantees and their respective areas served include:
Arizona: Valley of the Sun YMCA, Women's Health Innovations of Arizona Connecticut: Lifebridge Community Services, Inc., McCall Center for Behavioral Health, The Village for Families and Children Florida: You Thrive Florida, Eluna (FL, GA, IL, MO, PA, TN, TX), Frameworks of Tampa Bay Inc. Georgia: Communities in Schools of Georgia Inc., Atlanta Victim Assistance Inc. Illinois: Distinctive Schools, Illinois Afterschool Network Missouri: Center for Conflict Resolution, The Foundation for Barnes-Jewish Hospital, Logos Inc. New Jersey: Embright Education, Mastery Charter Schools (NJ, PA) Pennsylvania: Children's Hospital of Philadelphia Tennessee: STARS Nashville, The University of Tennessee Foundation Inc. Texas: Communities In Schools of the South Plains, Momentous Institute Together with its national partner, Boys & Girls Clubs of America, the Foundation is helping expand mental health support for young people in Clubs nationwide. Since the partnership began in 2024, 90 percent of Clubs — representing 11,000 staff — have completed trauma-informed training, and more than 250 teens have participated in a pilot of the Behavioral Support Toolkit.
Read about the recent impact of the improving youth mental health grant program here.
About The Cigna Group Foundation
The Cigna Group Foundation is a private foundation funded by contributions from The Cigna Group (NYSE:CI) and its subsidiaries. The Cigna Group Foundation aims to support, collaborate, and convene with nonprofit organizations addressing society's greatest health challenges. In addition to increasing access to programs and care in geographies demonstrating significant need, the Foundation responds with humanitarian aid relief during critical times and strengthens colleagues' support of causes through matching donations and volunteer rewards. To learn more, visit www.thecignagroup.com/community.
About The Cigna Group
The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Cigna Healthcare, Evernorth Health Services or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 countries and jurisdictions and has more than 187 million customer relationships around the world. Learn more at www.thecignagroup.com.
NOT FOR DISSEMINATION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA
TORONTO--(BUSINESS WIRE)--CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the CI ETFs for the month or quarter ending June 30, 2026. In all cases, the distribution will be paid on or before June 30, 2026 to unitholders of record on June 24, 2026. The ex-dividend date for all ETFs is June 24, 2026.
All CI ETFs trade on the Toronto Stock Exchange with the exception of the following, which trade on Cboe Canada: CI Canadian Equity ETF (CCDN); CI MSCI World ESG Impact Index ETF (CESG, CESG.B); CI Global Short-Term Bond Fund (ETF Series, CGSB); CI Global Healthcare Leaders ETF (CHCL.B); CI U.S. Treasury Inflation-linked Bond ETF (CTIP); CI U.S. 500 ETF (CUSA, CUSA.B); and CI U.S. 1000 ETF (CUSM.B).
ETF
Trading
Symbol
Distribution Amount
(per unit)
Payment
Frequency
CI 1-5 Year Laddered Government Strip Bond Index ETF
BXF
$0.0786
Quarterly
CI Canadian Aggregate Bond Index ETF
CAGG
$0.1290
Monthly
CI Canadian Short-Term Aggregate Bond Index ETF
CAGS
$0.1322
Monthly
CI Balanced Asset Allocation ETF
CBAL
$0.2415
Quarterly
CI Balanced+ Asset Allocation ETF Fund
CBAP
$0.0458
Quarterly
CI Galaxy Blockchain Index ETF
CBCX
$0.0000
Quarterly
CI Balanced Growth Asset Allocation ETF
CBGR
$0.2538
Quarterly
CI Balanced Income Asset Allocation ETF
CBIN
$0.3471
Quarterly
CI Digital Security Index ETF
CBUG
$0.0000
Quarterly
CI U.S. Aggregate Bond Covered Call ETF
CCBD
$0.0371
Monthly
CI Canadian Equity Index ETF
CCDN
$0.1938
Quarterly
CI Conservative Asset Allocation ETF
CCNV
$0.3028
Quarterly
CI Auspice Broad Commodity Fund (ETF Series)
CCOM
$1.0905
Quarterly
CI DoubleLine Total Return Bond US$ Fund (ETF Series)
CDLB
$0.0402
Monthly
CDLB.B
$0.0417
Monthly
CDLB.U
US$0.0417
Monthly
CI Equity+ Asset Allocation ETF Fund
CEQP
$0.0173
Quarterly
CI Equity Asset Allocation ETF
CEQT
$0.2037
Quarterly
CI MSCI World ESG Impact Index ETF
CESG
$0.2080
Quarterly
CESG.B
$0.2080
Quarterly
CI Floating Rate Income Fund (ETF Series)
CFRT
$0.0911
Monthly
CI Global Asset Allocation Private Pool (ETF Series)
CGAA
$0.0738
Monthly
CI Global Dividend Private Pool (ETF Series)
CGDI
$0.0230
Monthly
CI Global Minimum Downside Volatility Index Fund (ETF Series)
CGDV
$0.2189
Quarterly
CGDV.B
$0.2189
Quarterly
CI High Yield Bond Private Pool (ETF Series)
CGHY
$0.0228
Monthly
CGHY.U
US$0.0235
Monthly
CI Global Investment Grade ETF
CGIN
$0.0540
Monthly
CGIN.U
US$0.0540
Monthly
CI Global Quality Dividend Growth Index ETF
CGQD.B
$0.0000
Quarterly
CI Global Real Asset Private Pool (ETF Series)
CGRA
$0.0770
Monthly
CI Global Green Bond Fund (ETF Series)
CGRB
$0.0445
Monthly
CGRB.U
US$0.0461
Monthly
CI Global REIT Private Pool (ETF Series)
CGRE
$0.0860
Monthly
CI Global Sustainable Infrastructure Fund (ETF Series)
CGRN
$0.0500
Monthly
CGRN.U
US$0.0500
Monthly
CI Growth Asset Allocation ETF
CGRO
$0.2739
Quarterly
CI Global Short-Term Bond Fund (ETF Series)
CGSB
$0.0620
Monthly
CI Gold+ Giants Covered Call ETF
CGXF
$0.1417
Monthly
CGXF.U
US$0.1105
Monthly
CI Global Healthcare Leaders Index ETF
CHCL.B
$0.0000
Quarterly
CI ICBCUBS S&P China 500 Index ETF (formerly CI ICBCCS S&P China 500 Index ETF)
CHNA.B
$0.0000
Quarterly
CI Global Artificial Intelligence Fund (ETF Series)
CIAI
$0.0000
Quarterly
CI Canadian Banks Covered Call Income Class ETF
CIC
$0.0552
Monthly
CI Emerging Markets Alpha ETF
CIEM
$0.0731
Quarterly
CIEM.U
US$0.0731
Quarterly
CI Global Infrastructure Private Pool (ETF Series)
CINF
$0.0690
Monthly
CI Global Alpha Innovators ETF (formerly CI Global Alpha Innovation ETF)
CINV
$0.0000
Quarterly
CINV.U
US$0.0000
Quarterly
CI Munro Alternative Global Growth Fund (ETF Series)
CMAG
$0.0000
Quarterly
CMAG.U
US$0.0000
Quarterly
CI Marret Alternative Absolute Return Bond Fund (ETF Series)
CMAR
$0.0670
Monthly
CMAR.U
US$0.0670
Monthly
CI Alternative Diversified Opportunities Fund (ETF Series)
CMDO
$0.0640
Monthly
CMDO.U
US$0.0640
Monthly
CI Marret Alternative Enhanced Yield Fund (ETF Series)
CMEY
$0.0720
Monthly
CMEY.U
US$0.0720
Monthly
CI Money Market ETF
CMNY
$0.1002
Monthly
CI U.S. Enhanced Momentum Index ETF
CMOM
$0.0000
Quarterly
CMOM.B
$0.0000
Quarterly
CI Alternative North American Opportunities Fund (ETF Series)
CNAO
$0.0000
Quarterly
CNAO.U
US$0.0000
Quarterly
CI Alternative Investment Grade Credit Fund (ETF Series)
CRED
$0.0500
Monthly
CRED.U
US$0.0500
Monthly
CI High Interest Savings ETF
CSAV
$0.0850
Monthly
CI U.S. Treasury Inflation-Linked Bond Index ETF (CAD Hedged)
CTIP
$0.0141
Monthly
CI Target 2028 Investment Grade Bond Fund (ETF Series)
CTMA
$0.0413
Monthly
CI Target 2029 Investment Grade Bond Fund (ETF Series)
CTMB
$0.0352
Monthly
CI Target 2030 Investment Grade Bond Fund (ETF Series)
CTMC
$0.0343
Monthly
CI Global Unconstrained Bond Fund (ETF Series)
CUBD
$0.0769
Monthly
CI U.S. Minimum Downside Volatility Index ETF
CUDV
$0.0962
Quarterly
CUDV.B
$0.0962
Quarterly
CI U.S. Monthly Income Private Pool (ETF Series)
CUIG
$0.0288
Monthly
CUIG.U
US$0.0288
Monthly
CI U.S. 500 Index ETF
CUSA
$0.0000
Quarterly
CUSA.B
$0.0000
Quarterly
CI U.S. 1000 Index ETF
CUSM.B
$0.0000
Quarterly
CI Utilities Giants Covered Call ETF
CUTL
$0.0815
Monthly
CUTL.B
$0.0873
Monthly
CI U.S. Enhanced Value Index Fund (ETF Series)
CVLU
$0.1241
Quarterly
CVLU.B
$0.1241
Quarterly
CI Canadian Convertible Bond ETF
CXF
$0.0400
Monthly
CI U.S. Quality Dividend Growth Index ETF
DGR
$0.0000
Quarterly
DGR.B
$0.0000
Quarterly
DGR.U
US$0.0000
Quarterly
CI Canada Quality Dividend Growth Index ETF
DGRC
$0.0000
Quarterly
CI Europe Hedged Equity Index ETF
EHE
$0.5891
Quarterly
EHE.B
$0.5891
Quarterly
CI Emerging Markets Dividend Index ETF
EMV.B
$0.0000
Quarterly
CI Enhanced Government Bond ETF
FGO
$0.0678
Quarterly
FGO.U
US$0.0678
Quarterly
CI Health Care Giants Covered Call ETF
FHI
$0.0556
Monthly
FHI.B
$0.0655
Monthly
FHI.U
US$0.0490
Monthly
CI Investment Grade Bond ETF
FIG
$0.0320
Monthly
FIG.U
US$0.0248
Monthly
CI U.S. & Canada Lifeco Covered Call ETF
FLI
$0.0374
Monthly
CI Preferred Share ETF
FPR
$0.0768
Monthly
CI Enhanced Short Duration Bond Fund (ETF Series)
FSB
$0.0320
Monthly
FSB.U
US$0.0320
Monthly
CI Global Financial Sector ETF
FSF
$0.3026
Quarterly
CI Morningstar Canada Value Index ETF
FXM
$0.0000
Quarterly
CI International Quality Dividend Growth Index ETF
IQD
$0.0000
Quarterly
IQD.B
$0.0000
Quarterly
CI Japan Equity Index ETF
JAPN
$0.0000
Quarterly
JAPN.B
$0.0000
Quarterly
CI Energy Giants Covered Call ETF
NXF
$0.0448
Monthly
NXF.B
$0.0612
Monthly
NXF.U
US$0.0847
Monthly
CI North American Core Plus Bond ETF (formerly CI ONE North American Core Plus Bond ETF)
ONEB
$0.3451
Monthly
CI Global Core Plus Equity ETF (formerly CI ONE Global Equity ETF)
ONEQ
$0.0000
Quarterly
CI Morningstar National Bank Québec Index ETF
QXM
$0.0000
Quarterly
CI Canadian REIT ETF
RIT
$0.0675
Monthly
CI Tech Giants Covered Call ETF
TXF
$0.3779
Monthly
TXF.B
$0.4968
Monthly
TXF.U
US$0.2059
Monthly
CI U.S. MidCap Dividend Index ETF
UMI
$0.0000
Quarterly
UMI.B
$0.0000
Quarterly
CI U.S. Money Market ETF
UMNY.U
US$0.1495
Monthly
CI Morningstar International Value Index ETF
VXM
$0.0000
Quarterly
VXM.B
$0.0000
Quarterly
VXM.U
US$0.0000
Quarterly
CI Morningstar Canada Momentum Index ETF
WXM
$0.0000
Quarterly
CI Morningstar International Momentum Index ETF
ZXM
$0.6016
Quarterly
ZXM.B
$0.6016
Quarterly
Supporting Investors’ Needs
Stay in the market, minimize costs, and take advantage of a smart, simple and efficient feature designed to support investors’ needs. The CI Distribution Reinvestment Plan (DRIP) will automatically reinvest cash distributions into the CI ETF making the distribution. All of the distributions indicated in the table above will be paid in cash unless the unitholder has enrolled in the applicable DRIP of the respective ETF. For more information on how to enroll in DRIP and other considerations, please see the applicable ETF’s prospectus.
About CI Global Asset Management
CI Global Asset Management (“CI GAM”) is one of Canada’s leading investment management firms, providing a comprehensive suite of solutions – including mutual funds, exchange-traded funds and alternative investments – to help Canadians achieve their financial goals. Founded in 1965, CI GAM has built an enduring legacy of innovation, disciplined portfolio management and commitment to investor success. We partner with financial advisors, wealth management firms and institutions to serve more than 1.3 million investors. CI GAM is a subsidiary of Toronto-based CI Financial Corp., a diversified global asset and wealth management company. For more information, visit www.ci.com or follow us on LinkedIn.
Commissions, trailing commissions, management fees and expenses all may be associated with an investment in mutual funds and exchange-traded funds (ETFs). Please read the prospectus before investing. In the case of Money Market Funds, note that mutual fund securities are not covered by the Canada Deposit Insurance Corporation or by any other government deposit insurer. Important information about mutual funds and ETFs is contained in their respective prospectus. Mutual funds and ETFs are not guaranteed; their values change frequently, and past performance may not be repeated. You will usually pay brokerage fees to your dealer if you purchase or sell units of an ETF on recognized Canadian exchanges. If the units are purchased or sold on these Canadian exchanges, investors may pay more than the current net asset value when buying units of the ETF and may receive less than the current net asset value when selling them. An investor cannot invest directly in the Index. Performance of the ETF is expected to be lower than the performance of the Index.
This communication is intended for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to purchase mutual funds managed by CI Global Asset Management and is not, and should not be construed as, investment, tax, legal or accounting advice, and should not be relied upon in that regard. Every effort has been made to ensure that the material contained in this document is accurate at the time of publication. Individuals should seek the advice of professionals, as appropriate, regarding any particular investment. Investors should consult their professional advisors prior to implementing any changes to their investment strategies. These investments may not be suitable to the circumstances of an investor.
CI Liquid Alternative investment funds have the ability to invest in asset classes or use investment strategies that are not permitted for conventional mutual funds. The specific strategies that differentiate these investment funds from conventional fund structure include increased use of derivatives for hedging and non-hedging purposes; increased ability to sell securities short; and the ability to borrow cash to use for investment purposes. While these strategies will be used in accordance with the investment funds' investment objectives and strategies, during certain market conditions they may accelerate the pace at which your investment decreases in value.
CI Global Asset Management is licensed by WisdomTree, Inc. to use certain WisdomTree indexes (the “WisdomTree Indexes”) and WisdomTree marks.
“WisdomTree®” and “Variably Hedged®” are registered trademarks of WisdomTree, Inc. and WisdomTree, Inc. has patent applications pending on the methodology and operation of its indexes. The ETFs referring to such indexes (the “WT Licensee Products”) are not sponsored, endorsed, sold, or promoted by WisdomTree, Inc., or its affiliates ("WisdomTree"). WisdomTree makes no representation or warranty, express or implied, and shall have no liability regarding the advisability, legality (including the accuracy or adequacy of descriptions and disclosures relating to the WT Licensee Products) or suitability of investing in or purchasing securities or other financial instruments or products generally, or of the WT Licensee Products in particular (including, without limitation, the failure of the WT Licensee Products to achieve their investment objectives) or regarding use of such indexes or any data included therein.
The S&P China 500 Index CAD (the “S&P Index”) underlying the CI ICBCUBS S&P China 500 Index ETF (the “S&P Licensed ETF”) managed by the Manager is proprietary to S&P Dow Jones Indices LLC (“S&P DJI”). S&P® and the names identifying the S&P Index are trademarks of Standard & Poor’s Financial Services LLC and have been licensed for use by S&P DJI and sublicensed for certain purposes by the Manager. The S&P Licensed ETF based on the S&P Index is not in any way sponsored, endorsed, sold or promoted by S&P DJI, its affiliates or licensors and those parties make no representations or warranties, express or implied, regarding the advisability of investing in securities generally or in the S&P Licensed ETF particularly or the ability of the S&P Index to track general market performance.
MSCI is a trademark of MSCI Inc. The MSCI indexes have been licensed for use for certain purposes by CI Global Asset Management (“CI GAM”) in connection with the CI ETFs (the “ETFs”). The ETF and the securities referred to herein are not sponsored, endorsed or promoted by MSCI Inc. or any of its affiliates (collectively, “MSCI”) and MSCI bears no liability with respect to any such fund or securities or any index on which such fund or securities are based. The ETF’s prospectus contains a more detailed description of the limited relationship MSCI has with CI GAM and any related funds.
Morningstar® is a registered trademark of Morningstar, Inc. (“Morningstar”) Morningstar® Canada Value IndexTM , Morningstar® National Bank Québec IndexTM, Morningstar® Canada Momentum IndexTM, Morningstar® International Value I IndexTM, and Morningstar® International Momentum IndexTM (the “Index”) are service marks of Morningstar and have been licensed for use for certain purposes by CI Global Asset Management (“CI GAM”). The securities of each of the CI Morningstar ETFs (the “ETFs”) are not in any way sponsored, endorsed, sold or promoted by Morningstar or any of its affiliates (collectively, ‘‘Morningstar’’), and Morningstar makes no representation or warranty, express or implied regarding the advisability of investing in securities generally or in the ETFs particularly or the ability of the Index to track general market performance.
Auspice Capital Advisors Ltd., DoubleLine Capital LP, One Capital Management, LLC, Galaxy Digital Capital Management LP, and Munro Partners are portfolio sub-advisors to certain funds offered and managed by CI Global Asset Management.
The CI Exchange-Traded Funds (ETFs) are managed by CI Global Asset Management, a wholly owned subsidiary of CI Financial Corp.
CI Global Asset Management is a registered business name of CI Investments Inc.
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.
Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.
Zacks Premium includes access to the Zacks Style Scores as well.
What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.
Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFinding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to highlight the most attractive and discounted stocks.
Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.
Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.
VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.
It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +23.93% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.
That's where the Style Scores come in.
You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.
The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.
Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Cigna (CI - Free Report) Headquartered in Bloomfield, CT and formed in 1982, Cigna Corporation has rebranded itself as The Cigna Group. The company was formed as a result of a merger between Connecticut General Life Insurance Company and Insurance Company of North America. Cigna completed its combination with Express Scripts Holding Company by 2018-end. Shares of the new combined company trade on the NYSE under the stock ticker symbol “CI.”
CI is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
Additionally, the company could be a top pick for growth investors. CI has a Growth Style Score of B, forecasting year-over-year earnings growth of 1.8% for the current fiscal year.
Seven analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.06 to $30.37 per share. CI boasts an average earnings surprise of +1.9%.
With a solid Zacks Rank and top-tier Growth and VGM Style Scores, CI should be on investors' short list.
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.
Zacks Premium also includes the Zacks Style Scores.
What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.
Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.
Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.
VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.
How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.
Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.93% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.
That's where the Style Scores come in.
To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.
As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Cigna (CI - Free Report) Headquartered in Bloomfield, CT and formed in 1982, Cigna Corporation has rebranded itself as The Cigna Group. The company was formed as a result of a merger between Connecticut General Life Insurance Company and Insurance Company of North America. Cigna completed its combination with Express Scripts Holding Company by 2018-end. Shares of the new combined company trade on the NYSE under the stock ticker symbol “CI.”
CI is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
Momentum investors should take note of this Medical stock. CI has a Momentum Style Score of A, and shares are up 1.6% over the past four weeks.
For fiscal 2026, eight analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.07 to $30.38 per share. CI boasts an average earnings surprise of +1.9%.
With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, CI should be on investors' short list.
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.
It also includes access to the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.
Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.
Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.
VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.
How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.
It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +23.7% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.
That's where the Style Scores come in.
You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.
As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.
For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Cigna (CI - Free Report) Headquartered in Bloomfield, CT and formed in 1982, Cigna Corporation has rebranded itself as The Cigna Group. The company was formed as a result of a merger between Connecticut General Life Insurance Company and Insurance Company of North America. Cigna completed its combination with Express Scripts Holding Company by 2018-end. Shares of the new combined company trade on the NYSE under the stock ticker symbol “CI.”
CI is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
It also boasts a Value Style Score of A thanks to attractive valuation metrics like a forward P/E ratio of 9.52; value investors should take notice.
For fiscal 2026, eight analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.07 to $30.38 per share. CI boasts an average earnings surprise of +1.9%.
With a solid Zacks Rank and top-tier Value and VGM Style Scores, CI should be on investors' short list.
On May 12, 2026, The Cigna Group CI shares rose 3.6% to a current price of $298.49. The stock has experienced a 52-week range, with a high of $338.89 and a low of $239.51. This upward movement comes amid a year-to-date increase of 9.1%, although the stock is down 3.5% over the past year.
GF Value™ verdict: The current price of $298.49 is 30.6% undervalued compared to the GF Value™ estimate of $430.00.GF Score™: 72/100, indicating an above-average stock with potential for higher long-term returns.Most notable signal: Insiders sold $1.2M in the last 3 months, showing no buying activity. Is CI Overvalued or Undervalued? The current market price of The Cigna Group CI shares at $298.49 is significantly below the GF Value™ estimate of $430.00, indicating that the stock is 30.6% undervalued. This substantial margin of safety suggests that investors may have an opportunity to benefit from the potential upside. According to GuruFocus, the GF Valuation label classifies CI as significantly undervalued, which signals a favorable investment case, albeit with caution due to the lack of insider buying activity.
GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates. While the undervaluation suggests promise, it is essential to consider the lack of support from insider activity, which could indicate a lack of confidence among executives in the company's near-term prospects.
How Does CI's Valuation Compare to Its History? Metric Current Historical P/E (TTM) 12.7x 15.4x Forward P/E 9.9x N/A The current P/E (TTM) of 12.7x is 18% below its 5-year median P/E of 15.4x, indicating that the stock is trading at a lower valuation compared to its historical averages. Additionally, the forward P/E of 9.9x further supports the idea that CI is undervalued. This P/E analysis aligns with the GF Value™ verdict, reinforcing the notion that CI shares are currently undervalued.
What Does CI's GF Score™ Tell Us? Metric Rating GF Score™ 72 Financial Strength 6/10 Profitability 6/10 Growth 7/10 Valuation 4/10 Momentum 2/10 The GF Score™ of 72/100 reflects an above-average potential for CI, with the strongest area being growth, rated at 7/10. However, the valuation rank of 4/10 and momentum rank of 2/10 highlight the company's struggles in these areas. The moderate financial strength and profitability scores suggest that while CI has growth potential, there are challenges that could affect its overall performance.
What Are Insiders Doing with CI Stock? Recently, insiders have sold $1.2M worth of shares in The Cigna Group, with no buying activity reported. This trend could indicate a lack of confidence among insiders regarding the company’s short-term performance or outlook. The absence of insider buying may also suggest that insiders do not see immediate value in the current price levels, which could be a red flag for potential investors.
What This Means for Investors Based on the GF Value™ assessment, The Cigna Group CI is considered undervalued, with a significant margin of safety when compared to its intrinsic value. However, the lack of insider buying and lower momentum rank should be taken into account as potential risks for investors looking to capitalize on this valuation opportunity.
For the complete analysis, visit the The Cigna Group CI stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions What is CI's GF Score™?
CI's GF Score™ is 72/100, indicating that it is above average compared to other stocks and has the potential to deliver higher long-term returns.
Is CI overvalued or undervalued?
CI is considered undervalued, with a current price of $298.49 compared to a GF Value™ of $430.00, representing a 30.6% upside.
What is CI's P/E ratio?
CI's P/E (TTM) is 12.7x, which is 18% below its 5-year median of 15.4x, indicating that it is trading at a lower valuation compared to its historical averages.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced that Brian Evanko, President and Chief Operating Officer of The Cigna Group, will present at the BofA Securities 2026 Health Care Conference today, May 13, 2026, in Las Vegas, NV.
The Cigna Group's presentation is expected to begin at approximately 12:20 p.m. ET. A live webcast of the presentation will be available at https://investors.thecignagroup.com/events-and-presentations/default.aspx in the Investor Relations section of The Cigna Group's website.
To listen to this presentation live on the Internet, visit https://investors.thecignagroup.com/events-and-presentations/default.aspx at least 15 minutes prior to the presentation to download and install any necessary audio software.
About The Cigna Group
The Cigna Group (NYSE: CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Evernorth Health Services, Cigna Healthcare, or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 countries and jurisdictions, and has over 185 million customer relationships around the world. Learn more at thecignagroup.com.
Investor Relations Contact
Ralph Giacobbe
1 (860) 787-7968
[email protected]
Media Contact
Justine Sessions
1 (860) 810-6523
[email protected]
Key Takeaways CI reported Q1 2026 adjusted revenue growth of 4.7% year over year to $68.5 billion.Cigna expects at least $6.9B Evernorth operating income and $4.5B from Cigna Healthcare.Cigna raised its dividend to $1.56 per share while maintaining a higher-than-industry yield. The Cigna Group (CI - Free Report) is well poised for growth on the back of strong segmental performance, improving operating efficiency and shareholder-friendly moves. Based in Bloomfield, CT, Cigna has a market capitalization of $79.6 billion. The company’s shares have gained 7.2% year to date, underperforming the industry’s average increase of 20.1% over the same period.
Its forward P/E ratio of 9.35x is lower than the industry average of 17.72x, indicating a relatively attractive valuation. Supported by solid prospects, Cigna currently holds a Zacks Rank #3 (Hold) and has a Value Score of A.
Zacks Estimates for CIThe Zacks Consensus Estimate for 2026 earnings is pegged at $30.38 per share, suggesting a 1.8% year-over-year increase. Over the past month, estimates have witnessed seven upward revisions against one downward revision. The consensus estimate for 2026 revenues is pinned at $287.5 billion, indicating 4.7% year-over-year growth.
Cigna beat earnings estimates in each of the trailing four quarters, with the average surprise being 1.9%.
CI’s Growth DriversCI’s first-quarter 2026 adjusted income from operations rose 12% year over year, driven by strong growth in the Cigna Healthcare and Evernorth Health Services. The company expects Evernorth Health Services’ adjusted operating income, on a pre-tax basis, to reach at least $6.9 billion in 2026, while the Cigna Healthcare unit is expected to generate a minimum of $4.5 billion in 2026. Cigna’s first-quarter 2026 adjusted revenues increased 4.7% year over year to $68.5 billion.
Business mix shifts and improved operating efficiency are major positives. The adjusted SG&A expense ratio improved to 4.8% in the reported quarter from 5.8% a year ago. Evernorth Health Services introduced a transformative pharmacy benefits model that passes drug manufacturer discounts directly to customers at the point of sale, lowering out-of-pocket costs. Cigna plans to adopt this model for its fully insured customers starting in 2027 while also raising its 2026 profits outlook for the Cigna Healthcare segment.
Cigna continues to demonstrate a strong commitment to enhancing shareholder value. The company repurchased nearly 11.9 million shares for approximately $3.6 billion in 2025. Although it didn’t make any buybacks in the first quarter, management approved a 3.3% increase in the quarterly dividend in February 2026, raising it to $1.56 per share. Its current dividend yield of 2.12% is higher than the industry average of 1.94%.
CI: Risks to WatchThere are some factors that investors should keep an eye on.
The company’s total benefits and expenses have escalated over the past several years due to higher pharmacy and other service costs. Total benefits and expenses witnessed a year-over-year increase of 4% in 2024, 12% in 2025 and 4% in the first quarter of 2026. Pharmacy and other service costs increased 12% year over year, reflecting changes in claims composition. The persistent escalation of expenses might weigh on margin growth.
Cigna has been grappling with a significant debt level over the past several years. At the end of the first quarter of 2026, it had a long-term debt of $29.4 billion, significantly higher than the cash balance of $7 billion. Its long-term debt to total capital ratio of 40.9% is slightly above the industry average of 40.5%. The elevated leverage level is likely to keep pressure on the company’s interest expenses going forward.
Key PicksSome better-ranked stocks in the broader Medical space are BrightSpring Health Services, Inc. (BTSG - Free Report) , Globus Medical, Inc. (GMED - Free Report) and Centene Corporation (CNC - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for BrightSpring Health’s 2026 earnings is pegged at $1.64 per share, which has witnessed five upward revisions in the past 30 days, with no movement in the opposite direction. BTSG beat earnings estimates in three of the trailing four quarters and missed once, with the average surprise being 14.6%. The consensus estimate for 2026 revenues is pinned at $15.1 billion, implying 16.6% year-over-year growth.
The Zacks Consensus Estimate for Globus Medical’s 2026 earnings is pegged at $4.66 per share, indicating a 17.1% year over year increase. GMED beat earnings estimates in each of the trailing four quarters, with the average surprise being 26.3%. The consensus estimate for 2026 revenues is pinned at $3.2 billion, implying 8.8% year-over-year growth.
The Zacks Consensus Estimate for Centene’s 2026 earnings is pegged at $3.47 per share, which has witnessed nine upward revisions in the past 30 days, with no movement in the opposite direction. CNC beat earnings estimates in three of the trailing four quarters and missed once, with the average surprise being 74.9%. The consensus estimate for 2026 revenues is pinned at $190.8 billion.
Cigna Group is reiterated as a "Buy," driven by strong Q1 2026 results, raised guidance, and sustained business momentum. CI's pharmacy and behavioral health segments are fueling revenue growth, while divestitures and PBM reform temporarily temper 2026 earnings. Shares trade at a 25% discount to a $377 fair value estimate, offering potential 15% annual total returns through 2031.
CRANBURY, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Cigna Healthcare® has selected MJH Life Sciences® as a recipient of its 2025 gold-level Healthy Workforce Designation for demonstrating a strong commitment to improving the health and vitality of its employees through a workplace well-being program.
“At MJH Life Sciences, workforce vitality is our top priority, and we are honored to be recognized with the Cigna Healthy Workforce Designation,” said Mike Hennessy Jr., chairman and CEO of MJH Life Sciences. “We understand the important role employee well-being plays in an organization’s success and how healthy employees contribute to a more productive, satisfied workforce and positive business performance.”
“Vitality” is defined as the ability to pursue life with health, strength and energy. It is both a driver and an outcome of health and work/life engagement, and Cigna Healthcare believes it is essential not only for individuals, but also as a catalyst for business and community growth.
Research conducted as part of the Evernorth Vitality Index confirms that those with higher vitality experience better mental and physical health, along with higher levels of job satisfaction and performance, and stronger relationships with managers. With only one in five U.S. adults reporting high levels of vitality, associates have an opportunity to improve workplace well-being programs and support. A workplace well-being program that takes a comprehensive approach to employee health can be critical for boosting vitality and building a workforce that experiences better overall health and job productivity.
“Employers that prioritize workforce vitality by addressing workplace stress, promoting healthy behaviors and fostering a sense of competence, autonomy and connection are supporting employee well-being and driving organizational success,” said Bryan Holgerson, president of Cigna Healthcare U.S. “As a company committed to creating better health care experiences and outcomes, we’re proud to recognize and celebrate employers who are building cultures of well-being across all dimensions of vitality.”
The Cigna Healthy Workforce Designation evaluates organizations based on the core components of their well-being programs, including workforce insights; strategy and culture; health equity and social determinants of health; dimensions of vitality; and engagement and experience. Organizations recognized with this designation set the standard of excellence for organizational health and vitality. Cigna Healthcare’s selection of MJH Life Sciences for the gold-level designation reinforces the company’s efforts and progress in 2025 toward nurturing a healthy work culture.
ABOUT MJH LIFE SCIENCES
MJH Life Sciences is the largest privately held, independent, full-service health care engagement network in North America dedicated to delivering trusted health care news, education, and data-informed insights to over 7 million health care decision-makers across multiple channels. With a diverse portfolio of leading brands, events and multimedia solutions, we connect health care professionals with the latest advancements and expert perspectives. Committed to driving meaningful change in health care, we strive to make an impact through innovation and excellence. For more information about MJH, visit https://www.mjhlifesciences.com/.
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
Zacks Premium includes access to the Zacks Style Scores as well.
What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.
Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.
The Style Scores are broken down into four categories:
Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.
Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.
Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.
VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.
#1 (Strong Buy) stocks have produced an unmatched +23.7% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.
This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.
That's where the Style Scores come in.
You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.
The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Cigna (CI - Free Report) Headquartered in Bloomfield, CT and formed in 1982, Cigna Corporation has rebranded itself as The Cigna Group. The company was formed as a result of a merger between Connecticut General Life Insurance Company and Insurance Company of North America. Cigna completed its combination with Express Scripts Holding Company by 2018-end. Shares of the new combined company trade on the NYSE under the stock ticker symbol “CI.”
CI is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
It also boasts a Value Style Score of A thanks to attractive valuation metrics like a forward P/E ratio of 9.41; value investors should take notice.
Eight analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.06 to $30.37 per share. CI boasts an average earnings surprise of +1.9%.
With a solid Zacks Rank and top-tier Value and VGM Style Scores, CI should be on investors' short list.
A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by Novo Nordisk. REUTERS/Hollie Adams/Brendan McDermid/Combination/File Photo Purchase Licensing Rights, opens new tab
CompaniesNEW YORK, June 2 (Reuters) - Health insurer Cigna (CI.N), opens new tab will stop covering GLP-1 weight-loss drugs including Novo Nordisk's (NOVOb.CO), opens new tab Wegovy and Eli Lilly's (LLY.N), opens new tab Zepbound in its employee health plan effective July 1, according to materials viewed by Reuters on Tuesday.
Details of the change in the Cigna Group Medical Plan were announced in an email to employees on June 1.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
A Cigna spokesperson confirmed that it was ending the coverage.
“As availability has increased and new options have emerged, we've made the decision to end our plan's coverage for GLP-1s for weight loss," the spokesperson said. "We remain committed to supporting our employees’ health through a range of weight management programs and resources.”
Wildly popular GLP-1 drugs like Wegovy and Zepbound promote weight loss by mimicking a hormone that keeps the stomach feeling full.
In a document circulated to employees, Cigna suggested those currently using the medications can choose to pay for the drugs with cash through manufacturer sites or TrumpRx.
The cash-pay purchases will not apply toward a deductible or the amount of spending required before enrollees can use their health coverage, the document said.
The price of weight-loss drugs has been dropping in 2026 with the launch of Novo’s Wegovy pill and Lilly’s oral Foundayo, which feature prices that start at $149 per month for the lowest dose. Americans have been increasingly pushed to the cash-pay market for the medications.
At the same time, employers have been cutting back on their coverage of the drugs.
The spokesperson said the change will not impact coverage for plans outside of Cigna's employee health plan or coverage of the drugs for the treatment of type 2 diabetes.
Those currently using the medications have until June 30 to refill their prescription. Weight regain is common for patients who stop taking the medications, and benefits often fade within two years, early research has found.
Cigna said that for employees who had insurance approvals for the drugs, it would cover older, generic weight-loss drugs including phentermine, diethylpropion, benzphetamine and phendimetrazine, which are less effective than GLP-1s.
The Cigna Group operates health insurer Cigna, health services unit Evernorth and pharmacy benefit manager Express Scripts.
The company had 67,700 employees at the end of 2025, 88% of whom were based in the U.S.
Reporting by Amina Niasse; Editing by Caroline Humer and Bill Berkrot
Our Standards: The Thomson Reuters Trust Principles., opens new tab
A screen displays the logo for Cigna Corp. on the floor at the New York Stock Exchange (NYSE) in New York, U.S., July 16, 2019. REUTERS/Brendan McDermid Purchase Licensing Rights, opens new tab
CompaniesJune 12 (Reuters) - Cigna's (CI.N), opens new tab pharmacy benefits services unit Express Scripts on Friday requested that the court strike down an unlawful state law that would restrict access to prescription medications and health care for hundreds of thousands of residents in Tennessee.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Reporting by Sriparna Roy in Bengaluru; Editing by Joyjeet Das
Our Standards: The Thomson Reuters Trust Principles., opens new tab
